Group One Trading, L.P. Bio N Tech Se Transaction History

Group One Trading, L.P.

$2.81 Billion
Q3 2025

A detailed history of Group One Trading, L.P. transactions in Bio N Tech Se stock. As of the latest transaction made, Group One Trading, L.P. holds 57,030 shares of BNTX stock, worth $5.88 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

57,030

Previous 73,577 22.49%

Holding current value

$5.88 Million

Previous $7.83 Million 28.2%

% of portfolio

0.2%

Previous 0.29%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	SELL	$96.22 - $115.31 $1.59 Million - $1.91 Million	-16,547 Reduced 22.49%	57,030 $5.62 Million
Q2 2025 Aug 13, 2025	BUY	$86.65 - $120.54 $890,155 - $1.24 Million	10,273 Added 16.23%	73,577 $7.83 Million
Q1 2025 May 14, 2025	SELL	$91.06 - $126.88 $252,054 - $351,203	-2,768 Reduced 4.19%	63,304 $5.76 Million
Q4 2024 Feb 14, 2025	BUY	$99.72 - $122.68 $5.05 Million - $6.21 Million	50,615 Added 327.46%	66,072 $7.53 Million
Q3 2024 Nov 14, 2024	SELL	$78.36 - $124.66 $2.96 Million - $4.72 Million	-37,834 Reduced 71.0%	15,457 $1.84 Million

Q2 2024 Aug 14, 2024	BUY	$80.36 - $102.87 $504,017 - $645,200	6,272 Added 13.34%	53,291 $4.28 Million
Q1 2024 May 10, 2024	SELL	$88.96 - $112.35 $439,996 - $555,683	-4,946 Reduced 9.52%	47,019 $4.34 Million
Q4 2023 Feb 14, 2024	SELL	$90.91 - $112.75 $1.97 Million - $2.44 Million	-21,615 Reduced 29.38%	51,965 $5.48 Million
Q3 2023 Nov 09, 2023	BUY	$98.5 - $125.08 $4.31 Million - $5.47 Million	43,770 Added 146.83%	73,580 $7.99 Million
Q2 2023 Aug 09, 2023	BUY	$102.58 - $129.66 $76,114 - $96,207	742 Added 2.55%	29,810 $3.22 Million
Q1 2023 May 12, 2023	SELL	$122.57 - $153.67 $2.52 Million - $3.16 Million	-20,547 Reduced 41.41%	29,068 $3.62 Million
Q4 2022 Feb 09, 2023	SELL	$118.43 - $186.05 $43,937 - $69,024	-371 Reduced 0.74%	49,615 $7.45 Million
Q3 2022 Nov 09, 2022	SELL	$127.65 - $183.11 $5.84 Million - $8.38 Million	-45,789 Reduced 47.81%	49,986 $6.74 Million
Q2 2022 Aug 11, 2022	SELL	$123.25 - $186.24 $13.7 Million - $20.7 Million	-111,243 Reduced 53.74%	95,775 $14.3 Million
Q1 2022 May 12, 2022	BUY	$126.25 - $231.85 $7.5 Million - $13.8 Million	59,384 Added 40.22%	207,018 $35.3 Million
Q4 2021 Feb 11, 2022	BUY	$216.64 - $362.52 $11.7 Million - $19.6 Million	53,992 Added 57.66%	147,634 $38.1 Million
Q3 2021 Nov 12, 2021	BUY	$205.93 - $447.23 $5.9 Million - $12.8 Million	28,651 Added 44.08%	93,642 $25.6 Million
Q2 2021 Aug 10, 2021	SELL	$113.32 - $241.49 $492,262 - $1.05 Million	-4,344 Reduced 6.27%	64,991 $14.6 Million
Q1 2021 May 12, 2021	BUY	$85.73 - $119.5 $4.45 Million - $6.2 Million	51,874 Added 297.08%	69,335 $7.57 Million
Q4 2020 Feb 10, 2021	BUY	$72.71 - $129.54 $912,437 - $1.63 Million	12,549 Added 255.48%	17,461 $1.42 Million
Q3 2020 Nov 12, 2020	SELL	$57.81 - $104.17 $221,123 - $398,450	-3,825 Reduced 43.78%	4,912 $340,000
Q2 2020 Aug 13, 2020	BUY	$38.58 - $66.74 $337,073 - $583,107	8,737 New	8,737 $583,000

Others Institutions Holding BNTX

# of Institutions

319

Shares Held

43.6M

Call Options Held

1.15M

Put Options Held

1.36M

View Full List

About BioNTech SE

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $25B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

More about BNTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account

Group One Trading, L.P. Bio N Tech Se Transaction History